Hamel N - Search Results

1

No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck.

Hamel N, Black MJ, Ghadirian P, Foulkes WD. Hamel N, et al. Br J Cancer. 2000 Feb;82(4):757-9. doi: 10.1054/bjoc.1999.0993. Br J Cancer. 2000. PMID: 10732740 Free PMC article.

2

Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma.

Liu G, Ghadirian P, Vesprini D, Hamel N, Paradis AJ, Lal G, Gallinger S, Narod SA, Foulkes WD. Liu G, et al. Among authors: hamel n. Br J Cancer. 2000 May;82(10):1646-9. doi: 10.1054/bjoc.2000.1221. Br J Cancer. 2000. PMID: 10817498 Free PMC article.

3

Germline truncating mutations in both MSH2 and BRCA2 in a single kindred.

Thiffault I, Hamel N, Pal T, McVety S, Marcus VA, Farber D, Cowie S, Deschênes J, Meschino W, Odefrey F, Goldgar D, Graham T, Narod S, Watters AK, MacNamara E, Du Sart D, Chong G, Foulkes WD. Thiffault I, et al. Among authors: hamel n. Br J Cancer. 2004 Jan 26;90(2):483-91. doi: 10.1038/sj.bjc.6601424. Br J Cancer. 2004. PMID: 14735197 Free PMC article.

4

Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families.

Osher DJ, De Leeneer K, Michils G, Hamel N, Tomiak E, Poppe B, Leunen K, Legius E, Shuen A, Smith E, Arseneau J, Tonin P, Matthijs G, Claes K, Tischkowitz MD, Foulkes WD. Osher DJ, et al. Among authors: hamel n. Br J Cancer. 2012 Apr 10;106(8):1460-3. doi: 10.1038/bjc.2012.87. Epub 2012 Mar 13. Br J Cancer. 2012. PMID: 22415235 Free PMC article.

5

An absence of founder BRCA2 mutations in individuals with squamous cell carcinoma of the head and neck.

Hamel N, Manning A, Black MJ, Tonin PN, Foulkes WD. Hamel N, et al. Int J Cancer. 1999 Dec 10;83(6):803-4. doi: 10.1002/(sici)1097-0215(19991210)83:6<803::aid-ijc17>3.0.co;2-n. Int J Cancer. 1999. PMID: 10597198 Free article. No abstract available.

6

Increased risk of head and neck cancer in association with GSTT1 nullizygosity for individuals with low exposure to tobacco.

Hamel N, Karimi S, Hébert-Blouin MN, Brunet JS, Gilfix B, Ghadirian P, Black MJ, Narod SA, Foulkes WD. Hamel N, et al. Int J Cancer. 2000 Aug 1;87(3):452-4. Int J Cancer. 2000. PMID: 10897054 Free article. No abstract available.

7

Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer.

Chappuis PO, Hamel N, Paradis AJ, Deschênes J, Robidoux A, Potvin C, Cantin J, Tonin P, Ghadirian P, Foulkes WD. Chappuis PO, et al. Among authors: hamel n. Clin Genet. 2001 Jun;59(6):418-23. doi: 10.1034/j.1399-0004.2001.590606.x. Clin Genet. 2001. PMID: 11453973

8

Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer.

Goffin JR, Straume O, Chappuis PO, Brunet JS, Bégin LR, Hamel N, Wong N, Akslen LA, Foulkes WD. Goffin JR, et al. Among authors: hamel n. Br J Cancer. 2003 Sep 15;89(6):1031-4. doi: 10.1038/sj.bjc.6601195. Br J Cancer. 2003. PMID: 12966421 Free PMC article.

9

BRCA1:185delAG found in the San Luis Valley probably originated in a Jewish founder.

Makriyianni I, Hamel N, Ward S, Foulkes WD, Graw S. Makriyianni I, et al. Among authors: hamel n. J Med Genet. 2005 May;42(5):e27. doi: 10.1136/jmg.2004.029785. J Med Genet. 2005. PMID: 15863659 Free PMC article. No abstract available.

10

TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution.

Greenblatt MS, Chappuis PO, Bond JP, Hamel N, Foulkes WD. Greenblatt MS, et al. Among authors: hamel n. Cancer Res. 2001 May 15;61(10):4092-7. Cancer Res. 2001. PMID: 11358831

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page